Prescription drug · ANDA
Vigabatrin NDC 0054-0652
Vigabatrin 500 mg/1 · Tablet · Oral · Hikma Pharmaceuticals USA Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0054-0652-25 | 00054065225 | 100 TABLET in 1 BOTTLE (0054-0652-25)Marketed from Sep 9, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vigabatrin
- Generic name (nonproprietary)
- vigabatrin
- Active ingredients
- Vigabatrin — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Hikma Pharmaceuticals USA IncNDC labeler code 0054
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213104
- Marketing start
- Listing expires
- Identifiers
- Product ID 0054-0652_f575e137-5300-4e13-a40e-5573f6c8a066SPL ID f575e137-5300-4e13-a40e-5573f6c8a066SPL set ID 5ed8d293-b7d8-4c66-9c31-8075e6f99092RxCUI 199521UNII GR120KRT6KUPC 0300540652258
- Pharmacologic class
- Anti-epileptic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400054065225followed by a unit qualifier and the quantityPackage 00054-0652-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Vigabatrin tablets are indicated for the treatment of: • Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; Vigabatrin tablets are not indicated as a first line agent ( 1.1 ) • Infantile Spasms - monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin tablets are indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treat…
Excerpt only. Read the full label for complete information.
About NDC 0054-0652
- What is NDC 0054-0652?
- 0054-0652 is the product NDC for Vigabatrin, Vigabatrin 500 mg/1 tablet, listed with the FDA by Hikma Pharmaceuticals USA Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vigabatrin.
- What is the active ingredient?
- Vigabatrin.
- Who is the labeler?
- Hikma Pharmaceuticals USA Inc, NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vigabatrin?
- 17 other product NDCs are listed under this name. See all Vigabatrin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Vigabatrin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | Carnegie Pharmaceuticals LLC | 80005-167 | 80005-0167-11 |
| vigabatrin | Vigabatrin 500 mg/10mL | Powder, For solutionOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1494 | 70710-1494-08 |
| vigabatrin | Vigabatrin 500 mg/10mL | Powder, For solutionOral | Zydus Lifesciences Limited | 70771-1742 | 70771-1742-08 |
| Vigabatrin | Vigabatrin 500 mg/1 | For solutionOral | Amneal Pharmaceuticals NY LLC | 60219-1425 | 60219-1425-05 |
| Vigabatrin | Vigabatrin 50 mg/mL | For solutionOral | Novadoz Pharmaceuticals LLC | 72205-093 | 72205-0093-50 |
| Vigabatrin | Vigabatrin 500 mg/1 | TabletOral | Edenbridge Pharmaceuticals LLC. | 42799-950 | 42799-0950-01 |
| Vigabatrin | Vigabatrin 500 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-367 | 59651-0367-01 |
| vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1287 | 70710-1287-01 |
| vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1654 | 70771-1654-01 |
| Vigabatrin | Vigabatrin 500 mg/1 | Powder, For solutionOral | Aurobindo Pharma Limited | 59651-366 | 59651-0366-50 |